Stockscreener 앱 받기
0.2823
9.52%
-0.0297
시간 외 거래:
.28
-0.0023
-0.81%
전일 마감가:
$0.312
열려 있는:
$0.318
하루 거래량:
84,637
Relative Volume:
0.84
시가총액:
$39.60M
수익:
$121.91M
순이익/손실:
$1.83M
주가수익비율:
25.90
EPS:
0.0109
순현금흐름:
$7.75M
1주 성능:
-1.53%
1개월 성능:
-24.72%
6개월 성능:
-44.60%
1년 성능:
-63.37%
1일 변동 폭
$0.2823
$0.3219
1주일 범위
$0.2823
$0.3227
52주 변동 폭
$0.2702
$0.95
엑스탄트 Stock (XTNT) Company Profile
명칭
Xtant Medical Holdings Inc
전화
406-388-0480
주소
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.2823 | 39.60M | 121.91M | 1.83M | 7.75M | 0.0109 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
엑스탄트 Stock (XTNT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-05 | 개시 | BTIG Research | Buy |
| 2018-11-15 | 재확인 | Maxim Group | Buy |
| 2018-02-14 | 재확인 | Maxim Group | Buy |
엑스탄트 주식(XTNT)의 최신 뉴스
Xtant Medical Holdings stock trades at EUR 0.26 with USD 40.8 million market cap - ad-hoc-news.de
Xtant Medical reports 46.60 percent short-interest drop for Xtant Medical stock - ad-hoc-news.de
Xtant Medical reports an 85.30 percent short-interest drop for Xtant Medical stock - ad-hoc-news.de
Xtant Medical Holdings (XTNT) Slips to $0.32 as Shares Test Lower SupportBreadth Thrust - https://www.dars.gov.et/
Xtant Medical Holdings (XTNT) Slips to $0.32 as Shares Test Lower SupportPut Dominated - https://www.dars.gov.et/
Xtant Medical stock sits 66.32 percent below its 52-week high - AD HOC NEWS
Xtant: A Smaller Top Line, a Bigger Cash Question - Orthopedics This Week
Xtant: A Smaller Top Line, a Bigger Cash Question - Orthopedics This Week
Xtant Medical stock reports a second quarter revenue miss - AD HOC NEWS
Xtant Medical stock draws a USD 1.00 target from Lucid Capital - AD HOC NEWS
Xtant Medical Holdings, Inc. (XMS.SG) Analyst insights, Price targets and RecommendationsYahoo Finance - Yahoo Finance Singapore
Xtant Medical stock trades quietly as investors weigh recent financial trends - AD HOC NEWS
Xtant Medical Holdings stock holds steady as investors eye latest results - AD HOC NEWS
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference - Eastern Progress
Xtant Medical Holdings Inc. (XTNT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
XTNT stock focus shifts to latest medical device results and valuation - ad-hoc-news.de
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com Canada
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com South Africa
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com Nigeria
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com UK
Lucid Capital initiates Xtant Medical stock with buy rating - Investing.com
Xtant Medical Holdings Inc. (XTNT) Peer Comparison – Compare with Others - Value Research
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Xtant Medical Holdings Inc. (XTNT) Key Financial Ratios – Valuation, Profitability & More - Value Research
Xtant Medical Shares Surge 16% Following BioHorizons Deal to Distribute Prolifica in Dental Market - TechStock²
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - Sahm
XTNT SEC Filings, Jul-Aug 2025Xtant Medical Holdings, Inc. Filing Archive - Stock Titan
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Nigeria
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Canada
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - PR Newswire
Xtant Medical partners with BioHorizons for dental distribution - Investing.com
BioHorizons will exclusively sell Xtant’s growth factor in the U.S. and Canada - Stock Titan
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - Yahoo Finance
Xtant Medical Earnings Call: Growth Bets Amid Setbacks - TipRanks
ETFs Investing in Xtant Medical Holdings, Inc. Stocks - TradingView
Xtant (XTNT) Financial Results: Profit Per Share Falls Below Its Benchmark in the Latest Session; Price Move - vinanet.vn
Xtant Medical (XTNT) insider reports new stock transaction - Stock Titan
Xtant Medical (XTNT) insider updates SEC on stock transaction - Stock Titan
Xtant Medical (XTNT) grants COO 450K DSUs vesting 2027–30 - Stock Titan
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT) - theglobeandmail.com
Xtant Medical Q2 2026 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ... - Yahoo Finance
XTNT: Expanded sales force, new products, and asset sales drive growth and cash generation outlook - TradingView
Xtant Medical Holdings Releases Q2 2026 Financial Results - AlphaStreet
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
Xtant Medical Cuts 2026 Revenue Guidance After Weak Biologics Sales and Amnio Headwinds - Minichart
Xtant Medical Holdings, Inc. (XTNT) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com South Africa
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com Nigeria
XTNT: Revenue and margins fell sharply, with a net loss and heightened supply chain risks - TradingView
엑스탄트 (XTNT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.62%
3.65%
자본화:
|
볼륨(24시간):